QuatRx Withdraws IPO Registration As Market For Life Sciences Cools
ANN ARBOR - QuatRx Pharmaceuticals Co. announced unexpectedly Monday that it has withdrawn its Initial Public Offering registration with the Securities and Exchange Commission because of poor market conditions. In a statement, QuatRx Chief Financial Officer Gary Onn said the market has not been kind to life science companies and QuatRx didn?t think it could